Tevogen Bio (TVGNW) Set to Post Quarterly Earnings on Tuesday

Tevogen Bio (NASDAQ:TVGNW – Get Free Report) is anticipated to post its results before the market opens on Tuesday, November 24th. Analysts expect Tevogen Bio to announce earnings of ($2.5550) per share for the quarter.

Tevogen Bio Price Performance

Shares of TVGNW opened at $0.03 on Tuesday. The firm has a 50 day simple moving average of $0.06 and a 200-day simple moving average of $0.05. Tevogen Bio has a 1-year low of $0.03 and a 1-year high of $0.12.

About Tevogen Bio

(Get Free Report)

Tevogen Bio is a clinical-stage biotechnology company developing precision T-cell therapies. Its approach uses selected donor-derived T cells designed to recognize specific targets, with the goal of developing treatments for cancer and infectious diseases. The company’s pipeline includes investigational cell therapy candidates, including programs directed at viral targets. Tevogen also describes its ExacTcell platform as supporting the identification and development of targeted T-cell therapies.

Read More

Receive News & Ratings for Tevogen Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tevogen Bio and related companies with MarketBeat.com's FREE daily email newsletter.